Company news
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) news
Drugs Made In America Acquisition Corp. news releases on 6ix. Latest, May 14, 2026: Drugs Made In America Acquisition Corp. 1Q 2026: Net income $1.97M, EPS…
Press releases & updates
Drugs Made In America Acquisition Corp. 1Q 2026: Net income $1.97M, EPS $0.06— 10-Q Summary
May 14, 2026
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion
May 5, 2026
Drugs Made In America Acquisition 10-K: $0 revenue, $5.94M net income, ($0.28M) net loss
April 15, 2026
Drugs Made In America Acquisition Corp - Enters Loi For De-Spac With Power Analytics Global Corp - SEC Filing
April 8, 2026
Drugs Made In America Acquisition Secures $500,000 Financing; Issues $100,000 Interim Note
March 27, 2026
Drugs Made In America appoints Roger Bendelac as CEO after Lynn Stockwell's removal
March 6, 2026
Drugs Made In America Acquisition Corp. SEC 10-Q Report
November 18, 2025
Drugs Made In America Acquisition Corp. Releases Q1 2025 10-Q Report
May 19, 2025
Drugs Made In America Acquisition Corp. Releases 10-K Report Highlighting IPO Success and Strategic Focus
March 30, 2025